Tezepelumab FDA-approved for Self-administration by Patients with Severe Asthma
February 02, 2023

The approval offers patients the choice to administer the monoclonal antibody at home using a prefilled device or to continue to receive it in a clinical setting.

6 Questions on Severe Uncontrolled Asthma: Key Characteristics for Primary Care
February 01, 2023

Severe uncontrolled asthma is a clinical treatment challenge even with advanced biologic therapies available. Test your knowledge of a few key characteristics with a quick quiz.

Air Pollution Independently Linked to Asthma Exacerbation in Urban-dwelling Children
January 31, 2023

Asthma exacerbations in children living in low-income urban areas were significantly associated with reduced air quality and specific pollutants in a new analysis.

Tezepelumab Reduced Exacerbations in Severe, Uncontrolled Asthma, Regardless of Number of Additional Controller Medications
October 18, 2022

CHEST 2022. Tezepelumab significantly reduced AAER and improved lung function in patients taking 1, 2, or ≥3 long-acting β-agonists in addition to ICS.

Simple Primary Care Screening Tool Predicts Asthma Diagnosis in Preschoolers
October 07, 2022

The noninvasive, easily administered tool was able to predict at age 3 years children who would be diagnosed with asthma at age 5 years.

Inhaler Education with Teach-to-Goal Methods Improved Technique Among Older Adults with Asthma, COPD
August 02, 2022

Additional research into tailored metered-dose inhaler education is needed, according to authors of a recent study.

Continuity of Care for Asthma, COPD Patients Could Improve Survival, Cut Costs
July 08, 2022

When asthma and COPD patients have a continuous relationship with a single provider, ED visits/hospitalizations go down, survival goes up, finds a new systematic review.

Patients with Moderate or Severe Asthma Benefit from High-intensity Interval Training, Study Finds
June 20, 2022

New findings suggest that HIIT may be an effective aerobic exercise option for asthma patients.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
May 20, 2022

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Review of Biologic Treatments for Asthma Finds Inconsistent Effects on Airway Hyperresponsiveness
May 19, 2022

ATS 2022: Findings from a literature review provide insight into the mechanisms of airway hyperresponsiveness in asthma.